Clinical trials
Cardiogenic Shock clinical trials
Below are recruiting cardiogenic shock clinical trials, each written for real people, not researchers. We’re tracking 86 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06078436Recruiting
Early carvedilol for heart failure shock
This trial tests whether starting the heart failure medication carvedilol early, along with standard monitoring, can help people in cardiogenic shock (when the heart can't pump enough blood) due to a weak heart muscle. It aims to see if earlier treatment improves outcomes.
SeoulAges 19 years+ - NCT05415332Recruiting
Tracking outcomes for cardiogenic shock in ICU
This study looks at how people with cardiogenic shock (or very low blood pressure from heart causes) do after treatment in a specialized cardiovascular ICU. It also examines whether care by heart critical-care specialists affects outcomes.
SeoulAges 19 years+ - NCT05879276RecruitingPhase 3
Early empagliflozin for shock patients after ICU start
This trial studies whether starting empagliflozin early in adults with cardiogenic shock helps people live longer and have fewer hospital returns, while also checking heart pumping and kidney function. It may help some ICU patients, but eligibility is strict and depends on kidney function and prior medication use.
Ars-LaquenexyAges 18 years+ - NCT05366452Recruiting
Early heart pump implant for shock after a heart attack
This trial studies whether putting in a small heart pump early (through the leg) helps people with a heart attack complicated by severe heart weakness (“cardiogenic shock”) compared with standard treatment. It aims to improve survival and recovery by supporting blood flow sooner.
Marseille, Bouche DU RhoneAges 18–80 - NCT05586282Recruiting
Study proteins that may worsen fluid leaks in shock
This trial studies specific body proteins to understand why fluid can leak from blood vessels during dangerous shock after infection or heart problems. If you (or your representative) qualify, your team will collect information and possibly samples to see whether these proteins relate to recovery and treatment response.
ParisAges 18 years+ - NCT05146336Recruiting
CytoSorb registry for critically ill patients needing blood treatment
This registry collects information about critically ill patients who receive the CytoSorb 300 mL blood treatment. It may help doctors better understand when the treatment works best and when it should not be used.
KlagenfurtAges Any age - NCT07769528Recruiting
Heart pump support for severe heart failure
This study tests a device that helps the heart pump blood when it is too weak to do so, even with medicine, after surgery, or while waiting for a transplant. It aims to see if it's safe and works well.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07656259Recruiting
Comparing breathing support methods in the heart ICU
This study compares different ways to support breathing in patients who need a ventilator in the cardiac intensive care unit. It aims to find the best approach for people with certain heart conditions, like cardiogenic shock or heart failure.
Rochester, MinnesotaAges 18 years+ - NCT06792643RecruitingPhase 2
Cangrelor for heart attack patients on heart-lung support
This trial tests whether adding a fast-acting anti-clotting drug (cangrelor) helps people having a massive heart attack who need a heart-lung machine (VA-ECMO). The goal is to see if it reduces clotting risks without causing dangerous bleeding.
Milan, ItalyAges 18 years+ - NCT04330651Recruiting
Extra-support machine for heart patients after surgery
This study looks at using an external life-support machine after heart surgery. It may help patients who need temporary extra support while the heart and body recover.
FlorenceAges 18–80 - NCT06081205Recruiting
Heart disease patients in intensive care study
This trial observes patients admitted to the cardiac intensive care unit with acute heart or blood vessel problems. It aims to learn more about their conditions and treatments.
Ioannina, EpirusAges Any age - NCT04158479Recruiting
Registry for people on ECMO life support
This registry collects information about people who are placed on ECMO, a heart-lung machine used to support breathing and/or circulation. It may help doctors better understand who benefits and how to manage ECMO in the future.
Beijing, Beijing MunicipalityAges Any age - NCT06644963Recruiting
Impella heart pump study: safety and complications
This study reviews how well people tolerated the Impella heart pump during cardiogenic shock and what complications occurred. It looks at past cases from 2010 to 2022 to help doctors understand the safety of this device.
MontpellierAges 18 years+ - NCT06645990Recruiting
Comparing Heart Pumps for Shock With ECMO
This study compares two support devices (Impella vs. IABP) for people with cardiogenic shock who are already on ECMO. It looks at how well the left side of the heart recovers when one of these devices is added.
MontpellierAges 18 years+ - NCT06662084Recruiting
Liver enzyme function in people with cardiogenic shock on heart pumps
This study tests whether your liver’s drug-processing enzymes (CYP) work normally during cardiogenic shock when you are on a heart pump like ECMO or Impella®. The goal is to help doctors choose the right medicines for you.
GenevaAges 18 years+ - NCT07596446Recruiting
Emergency treatment study for cardiac arrest patients
This study tests emergency treatments for people who have had a cardiac arrest (heart stops beating) outside the hospital. It looks at two groups: people whose hearts stop despite CPR efforts, and people whose hearts have restarted. The goal is to see if these treatments can help patients survive and recover better.
PragueAges 18–70 - NCT04117230Recruiting
Registry for heart support devices after severe circulation problems
This study is a registry that collects information from adults who need a temporary heart circulation support device such as VA-ECMO or an Impella pump (or newer similar devices). It may help doctors better understand which patients benefit most and how these devices are used in real life.
BaselAges 18 years+ - NCT07527156RecruitingPhase 4
Ketones through a nose tube for severe heart failure
This trial tests whether giving a special liquid diet (ketones) through a thin tube in your nose helps your heart pump better when it's severely weakened and not getting enough blood to your body. Ketones are an alternative fuel your body can use instead of glucose.
Prague, PragueAges 18 years+ - NCT07515508Recruiting
Understanding heart failure patterns in hospitalized patients
This study investigates different types of acute heart failure in hospitalized patients to better understand their condition and improve treatment. Researchers will use multiple imaging and testing methods to create a detailed picture of each patient's heart failure.
Bad KrozingenAges 18 years+ - NCT07508891Recruiting
Studying heart failure types in hospitalized patients
This trial looks at different types of acute heart failure in people who are hospitalized. Doctors will study your symptoms and health to better understand heart failure patterns, which might help improve future treatments.
HamburgAges 18 years+ - NCT06766006Recruiting
Heart-lung machine left ventricle unloading study
This study looks at how to best relieve pressure on the heart while a heart-lung machine is helping to pump blood. It includes anyone who needs this support.
MaastrichtAges 1 day–80 years - NCT07402018Recruiting
Aortic balloon pump study
This trial looks at how well the heart's pumping is helped by using an intra-aortic balloon pump, a device inserted to support blood flow in people with cardiogenic shock. It aims to learn more about how the device works and improve care.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07374289Recruiting
CPR and life support before hospital in Ostrava
This trial is testing a way to start CPR and emergency life support (ECPR) at the scene of a cardiac arrest in Ostrava. It might help if you or a loved one has a witnessed cardiac arrest that is likely caused by a heart problem, and you're under 70 years old.
Ostrava, Moravian-Silesian RegionAges 18–70 - NCT06162247Recruiting
Registry study for heart patients in intensive care
This study tracks patients with sudden heart problems admitted to a special heart intensive care unit. It helps doctors learn more about these conditions to improve future care.
NaplesAges 18 years+
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiogenic shock?
- Yes. Clin2 currently lists 86 recruiting cardiogenic shock studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiogenic shock trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiogenic shock trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.